Brown Advisory Inc. Sells 63,375 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS)

Brown Advisory Inc. trimmed its position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 4.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,534,028 shares of the company's stock after selling 63,375 shares during the period. Brown Advisory Inc. owned approximately 6.33% of OrthoPediatrics worth $35,559,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the business. R Squared Ltd acquired a new stake in OrthoPediatrics in the 4th quarter worth $48,000. KLP Kapitalforvaltning AS bought a new position in OrthoPediatrics during the fourth quarter valued at about $79,000. AlphaCentric Advisors LLC acquired a new position in OrthoPediatrics in the 4th quarter valued at approximately $171,000. Wells Fargo & Company MN grew its holdings in shares of OrthoPediatrics by 31.1% during the 4th quarter. Wells Fargo & Company MN now owns 9,853 shares of the company's stock worth $228,000 after purchasing an additional 2,338 shares in the last quarter. Finally, HighTower Advisors LLC bought a new stake in shares of OrthoPediatrics during the fourth quarter valued at approximately $268,000. 69.05% of the stock is owned by institutional investors.

Insider Activity at OrthoPediatrics

In related news, General Counsel Daniel J. Gerritzen sold 5,310 shares of the stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total transaction of $132,006.60. Following the completion of the transaction, the general counsel now owns 110,767 shares in the company, valued at approximately $2,753,667.62. This represents a 4.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO David R. Bailey sold 6,620 shares of the business's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $164,573.20. Following the sale, the chief executive officer now directly owns 319,155 shares in the company, valued at $7,934,193.30. This trade represents a 2.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 23,732 shares of company stock worth $589,978. 32.70% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

KIDS has been the topic of a number of recent research reports. Stifel Nicolaus decreased their price target on shares of OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating on the stock in a research note on Wednesday, March 5th. Piper Sandler decreased their price target on OrthoPediatrics from $40.00 to $30.00 and set an "overweight" rating on the stock in a research report on Thursday. Truist Financial reduced their price objective on OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating on the stock in a research note on Friday, April 11th. Needham & Company LLC reaffirmed a "buy" rating and issued a $42.00 price target on shares of OrthoPediatrics in a report on Thursday. Finally, Lake Street Capital assumed coverage on shares of OrthoPediatrics in a report on Monday, April 7th. They set a "buy" rating and a $37.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, OrthoPediatrics currently has an average rating of "Moderate Buy" and a consensus target price of $35.83.

OrthoPediatrics Trading Down 4.5 %

KIDS stock traded down $1.04 during midday trading on Friday, reaching $22.04. The company's stock had a trading volume of 130,348 shares, compared to its average volume of 196,870. The business's 50-day simple moving average is $23.08 and its 200-day simple moving average is $24.08. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19. OrthoPediatrics Corp. has a 52 week low of $20.25 and a 52 week high of $35.99. The stock has a market cap of $535.29 million, a PE ratio of -17.92 and a beta of 1.09.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported ($0.39) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.13). The company had revenue of $52.41 million for the quarter, compared to analyst estimates of $51.68 million. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. As a group, sell-side analysts expect that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.